AXON
Price
$291.14Alerts
Change
-$15.84 (-5.16%)
Updated
Nov 20 closing price
Capitalization
25.43B
101 days until earnings call
Intraday BUY SELL Signals
DTIL
Price
$7.40Alerts
Change
+$0.49 (+7.09%)
Updated
Nov 20 closing price
Capitalization
292.58M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AXON vs DTIL

AXON vs DTIL Comparison Chart in %
View a ticker or compare two or three
VS
AXON vs. DTIL commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and DTIL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AXON with price predictions
Nov 20, 2026

AXON's RSI Oscillator descending into oversold zone

The RSI Oscillator for AXON moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 270 of 367 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 52 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).

A.I.Advisor
a Summary for DTIL with price predictions
Nov 20, 2026

DTIL's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for DTIL moved out of overbought territory on November 10, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In 20 of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DTIL as a result. In 76 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for DTIL turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 39 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DTIL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

DTIL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

DTIL moved above its 50-day moving average on November 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DTIL crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +30.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DTIL advanced for three days, in 188 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 70 of 98 cases where DTIL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.460) is normal, around the industry mean (3.596). P/E Ratio (-8.480) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (2.997) is also within normal values, averaging (443.347).

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. DTIL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DTIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AXON vs DTIL: Fundamental Ratings
AXON
DTIL
OUTLOOK RATING
1..100
5691
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
8199
PRICE GROWTH RATING
1..100
6548
P/E GROWTH RATING
1..100
7789
SEASONALITY SCORE
1..100
1390

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for AXON (90). This means that DTIL’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (82) in the Biotechnology industry is in the same range as DTIL (100). This means that AXON’s stock grew similarly to DTIL’s over the last 12 months.

AXON's SMR Rating (81) in the Biotechnology industry is in the same range as DTIL (99). This means that AXON’s stock grew similarly to DTIL’s over the last 12 months.

DTIL's Price Growth Rating (48) in the Biotechnology industry is in the same range as AXON (65). This means that DTIL’s stock grew similarly to AXON’s over the last 12 months.

AXON's P/E Growth Rating (77) in the Biotechnology industry is in the same range as DTIL (89). This means that AXON’s stock grew similarly to DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONDTIL
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (AXON: $291.14 vs. DTIL: $7.40)
Brand notoriety: AXON and DTIL are both not notable
AXON represents the Aerospace & Defense, while DTIL is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 155% vs. DTIL: 127%
Market capitalization -- AXON: $25.43B vs. DTIL: $292.58M
AXON [@Aerospace & Defense] is valued at $25.43B. DTIL’s [@Biotechnology] market capitalization is $292.58M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $4.49 to $1.77T. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Aerospace & Defense] industry is $36.83B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 0 FA rating(s) are green while DTIL’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 0 green, 5 red.
  • DTIL’s FA Score: 1 green, 4 red.
According to our system of comparison, DTIL is a better buy in the long-term than AXON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while DTIL’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 5 bearish.
  • DTIL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -7.70% price change this week, while DTIL (@Biotechnology) price change was -2.18% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -16.06%. For the same industry, the average monthly price growth was -17.09%, and the average quarterly price growth was -35.29%.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

AXON is expected to report earnings on Mar 02, 2027.

DTIL is expected to report earnings on Mar 18, 2027.

Industries' Descriptions

@Aerospace & Defense (-16.06% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRAI1.480.02
+1.37%
Braiin Limited
TLK10.98-0.24
-2.14%
PT Telekomunikasi Indonesia
WU5.92-0.15
-2.47%
Western Union Company (The)
CYAB0.06N/A
-3.39%
Cyabra Inc.
BSIN0.93-0.05
-4.98%
Big Sky Industrial Inc